Details of the Drug

General Information of Drug (ID: DMSCR2H)

• Drug Name: Cerdulatinib
• Synonyms: PRT-062070; Syk + JAK multikinase inhibitor (NHL/CLL/RA), Portola Pharmaceuticals

Indication

Disease Entry	ICD 11	Status	REF
B-cell lymphoma	2A86	Phase 2	[1]
Non-hodgkin lymphoma	2B33.5	Phase 1/2	[2]
Atopic dermatitis	EA80	Phase 1	[3]
Vitiligo	ED63.0	Phase 1	[3]

• #Ro5 Violations (Lipinski): 0:
  Molecular Weight (mw); 445.5
  Logarithm of the Partition Coefficient (xlogp); 1.9
  Rotatable Bond Count (rotbonds); 8
  Hydrogen Bond Donor Count (hbonddonor); 3
  Hydrogen Bond Acceptor Count (hbondacc); 9
• Chemical Identifiers:
  Formula: C20H27N7O3S
  IUPAC Name: 4-(cyclopropylamino)-2-[4-(4-ethylsulfonylpiperazin-1-yl)anilino]pyrimidine-5-carboxamide
  Canonical SMILES: CCS(=O)(=O)N1CCN(CC1)C2=CC=C(C=C2)NC3=NC=C(C(=N3)NC4CC4)C(=O)N
  InChI: InChI=1S/C20H27N7O3S/c1-2-31(29,30)27-11-9-26(10-12-27)16-7-5-15(6-8-16)24-20-22-13-17(18(21)28)19(25-20)23-14-3-4-14/h5-8,13-14H,2-4,9-12H2,1H3,(H2,21,28)(H2,22,23,24,25)
  InChIKey: BGLPECHZZQDNCD-UHFFFAOYSA-N
• Cross-matching ID:
  PubChem CID: 44595079
  CAS Number: 1198300-79-6
  DrugBank ID: DB15499
  TTD ID: D0BI3N
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Janus kinase 1 (JAK-1)	TT6DM01	JAK1_HUMAN	Inhibitor	[3]
Janus kinase 2 (JAK-2)	TTRMX3V	JAK2_HUMAN	Modulator	[4]
Janus kinase 3 (JAK-3)	TTT7PJU	JAK3_HUMAN	Inhibitor	[3]
Tyrosine-protein kinase SYK (SYK)	TTOU65C	KSYK_HUMAN	Modulator	[4]

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [2] Clinical pipeline report, company report or official report of Portola.
• [3] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [4] Company report (Portola Pharmaceuticals)